InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
1
T+90 hit rate
44%
T+90 mean return
-5.6%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by HENNEMAN JOHN B III, Director. Director active across 9 companies, notably Anika Therapeutics, Inc.. In total, 30 disclosures have been published. Breakdown: 3 buys · 1 sell. Total volume traded: €186k. Activity tracked since 18 May 2021. The latest transaction was filed on 20 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations30 total
14,164 shares0Common StockSEC:0001171843-25-004067:0
87,765 shares@ US$14.3090.9% of flowCommon StockSEC:0000950170-24-128856:0
5,771 shares0Common StockSEC:0001171843-24-003906:0
1,045 shares0Common StockSEC:0001104659-24-073941:0
15,152 shares@ US$12.87100.0% of flowCommon StockSEC:0000950170-24-075301:0
15,651 shares0Common StockSEC:0001628280-24-025050:0
6,860 shares@ US$7.29100.0% of flowCommon StockSEC:0001104659-24-034671:0
Ideal exit: 8 Dec 2024 (T+270)
500 shares0Common StockSEC:0001104659-23-095019:0
50,000 shares@ US$2.619.1% of flowCommon StockSEC:0001628280-23-028615:0
6,500 shares0Common StockSEC:0001171843-23-003959:0
11,324 shares0Common StockSEC:0001628280-23-019151:0
14,354 shares0Common StockSEC:0001209191-23-008128:0
82,654 sharesCommon StockSEC:0001637761-23-000041:0
14,052 shares0Common StockSEC:0001209191-23-002654:0
5,995 shares0Common StockSEC:0001104659-22-084765:0
54,751 sharesCommon StockSEC:0000899243-22-023862:0
60,790 sharesCommon StockSEC:0000899243-22-023836:0
7,954 shares0Common StockSEC:0001171843-22-004299:0
15,943 shares0Common StockSEC:0001637761-22-000096:0
5,151 sharesCommon StockSEC:0001628280-22-015245:0
4,610 shares0Common StockSEC:0001567619-21-012875:0
4,610 shares0Common StockSEC:0001567619-21-012875
4,172 shares0Common StockSEC:0001171843-21-004426
4,172 shares0Common StockSEC:0001171843-21-004426:0
6,253 shares0Common StockSEC:0001637761-21-000130:0
25 of 30 declarations
About HENNEMAN JOHN B III
John B. Henneman III is a Director at Anika Therapeutics, Inc., SeaSpine Holdings Corp, and Aprea Therapeutics, Inc. He plays a vital role in overseeing the activities and strategies of these companies. His expertise in biotechnology and medical devices allows him to make significant contributions to the boards. John is committed to promoting innovation and growth in these sectors.
